Advanced search
Publication Cover
Future Oncology Volume 17, 2021 - Issue 30
Submit an article Journal homepage
2,139
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Real-World Efficacy of Docetaxel Plus Nintedanib After Chemo-Immunotherapy Failure in Advanced Pulmonary Adenocarcinoma

Martin Metzenmacher1 Department of Medical Oncology, West German Cancer Center,University Hospital Essen,Hufelandstrasse 55, Essen 45122, GermanyORCID Iconhttps://orcid.org/0000-0001-5395-9010View further author information
ORCID Icon,
Filippo Rizzo2 Department of Medical Oncology/Hematology, Evang,Kliniken Essen-Mitte,Essen, GermanyView further author information
,
Kato Kambartel3 Department of Pneumology & Allergy, Lung Cancer Center,Bethanien Hospital Moers,GermanyView further author information
,
Jens Panse4 Department of Oncology, Haematology, Haemostaseology & Stem Cell Transplantation,University Hospital RWTH Aachen,Aachen, GermanyORCID Iconhttps://orcid.org/0000-0001-6316-3112View further author information
ORCID Icon,
Diana Schaufler5 University of Cologne, Faculty of Medicine & University Hospital of Cologne; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Dusseldorf; Network Genomic Medicine,Lung Cancer Group Cologne,Cologne, GermanyView further author information
,
Matthias Scheffler5 University of Cologne, Faculty of Medicine & University Hospital of Cologne; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Dusseldorf; Network Genomic Medicine,Lung Cancer Group Cologne,Cologne, GermanyView further author information
,
Ivo Azeh6 Onkologische Gemeinschaftspraxis und Tagesklinik,Gelsenkirchen, GermanyView further author information
,
Mathias Hoiczyk7 Department of Gastroenterology, Hematology, Oncology, Diabetology & Rheumatology,Marien-Hospital Wesel,Pastor-Janßen-Straße 8-38, Wesel 46483, GermanyORCID Iconhttps://orcid.org/0000-0002-9031-1368View further author information
ORCID Icon,
Amin T Turki1 Department of Medical Oncology, West German Cancer Center,University Hospital Essen,Hufelandstrasse 55, Essen 45122, Germany;8 Department of Hematology & Stem Cell Transplantation, West German Cancer Center, University Hospital Essen,University of Duisburg-Essen,Hufelandstrasse 55, Essen 45122, GermanyView further author information
,
Judith Atz9 Boehringer Ingelheim Pharma GmbH & Co. KG,Ingelheim, GermanyView further author information
,
Hannes Buchner10 Staburo GmbH,Munich, GermanyView further author information
,
Christopher Hoffmann9 Boehringer Ingelheim Pharma GmbH & Co. KG,Ingelheim, GermanyORCID Iconhttps://orcid.org/0000-0001-8529-9678View further author information
ORCID Icon &
Daniel C Christoph2 Department of Medical Oncology/Hematology, Evang,Kliniken Essen-Mitte,Essen, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3151-6427View further author information
ORCID Icon show all
Pages 3965-3976 | Received 06 Apr 2021, Accepted 25 Jun 2021, Published online: 21 Jul 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.